Drug Discovery Technologies - A Global Market Overview

October 2026 | 265 pages | ID: DE54339D6E4EN
Industry Experts

Abstracts

Global Drug Discovery Technologies Market Trends and Outlook

Drug discovery technologies comprise a broad range of platforms and tools used to identify, validate, screen, and optimize therapeutic candidates during pharmaceutical and biotechnology research. These technologies include bioanalytical assays, bioinformatics, cell based assays, genomic technologies, high throughput screening (HTS), proteomic technologies, and other advanced discovery tools that help accelerate the development of new drugs. The growing integration of artificial intelligence, machine learning, genomics, and high-content screening is transforming traditional drug discovery workflows by improving efficiency, reducing development timelines, and enhancing candidate selection accuracy.

The global Drug Discovery Technologies market was valued at US$151.2 billion in 2025 and is projected to reach US$327.3 billion by 2032, registering a CAGR of 11.7% during the forecast period. Market growth is being driven by increasing pharmaceutical and biotechnology R&D investments, rising adoption of AI-powered drug discovery platforms, expanding use of genomic and proteomic technologies, growing prevalence of chronic and immunological diseases, and increasing demand for precision medicine. The United States remains the largest regional market, while Asia-Pacific is expected to witness the fastest growth through 2032. Among technologies, High Throughput Screening maintains the largest market share, while Genomic Technologies is emerging as the fastest-growing segment owing to advances in sequencing technologies and personalized medicine applications.

Drug Discovery Technologies Regional Market Analysis

The United States dominated the market in 2025 with US$67 billion, accounting for 44.3% of global revenue, supported by strong pharmaceutical R&D investments, advanced biotechnology infrastructure, and widespread adoption of AI-driven drug discovery platforms. Europe ranked second, closely followed by Asia-Pacific. However, Asia-Pacific is forecast to be the fastest-growing regional market, expanding at a 14.1% CAGR through 2032, driven by increasing research funding, expanding biopharmaceutical industries, and growing adoption of advanced genomic and bioinformatics technologies.

Drug Discovery Technologies Market Analysis by Technology

High Throughput Screening (HTS) was the largest technology segment in 2025, accounting for 25.8% of the global market, followed closely by Bioanalytical Assays. Genomic Technologies is expected to be the fastest-growing segment, registering a 14.3% CAGR through 2032, driven by increasing adoption of precision medicine, genomic sequencing, and AI-enabled target identification. Proteomic Technologies and Bioinformatics also demonstrate strong growth, reflecting rising demand for advanced data analytics and biomarker discovery. By 2032, HTS will remain the leading technology, while Genomic Technologies will expand its share to 12%, highlighting the growing importance of genomics in modern drug discovery workflows.

Drug Discovery Technologies Market Report Scope

This global report on Drug Discovery Technologies analyzes the market based on technology for the period 2022-2032 with projections from 2025 to 2032 in terms of value in US$. In addition to providing profiles of major companies operating in the Drug Discovery Technologies industry, the latest corporate, product and industrial developments have been covered to offer a clear panorama of Drug Discovery Technologies industry.

Key Metrics

Historical Period: 2022-2025
Base Year: 2025
Forecast Period: 2025-2032
Units: Value market in US$
Companies Mentioned: 50+

Global Drug Discovery Technologies Market by Geographic Region

• The United States
• Europe
• Asia-Pacific
• Rest of World

Global Drug Discovery Technologies Market by Technology

• Bioanalytical Assays
• Bioinformatics
• Cell Based Assays
• Genomic Technologies
• High Throughput Screening (HTS)
• Proteomic Technologies
• Other

Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
  Product Outline
    Backdrop
    What Is Drug Discovery?
    Screening and Design
    Omics in Drug Discovery and Development
    Process of Discovering Improved Drugs Provided by a Technological Revolution
    Drug Discovery Technologies
    Bioanalytical Assays
    Bio-Analytical Techniques
    Sample Extraction
    Bioinformatics
    Computer-Aided Drug Design
    Cell Based Assays
    Cell-Based Assays in High-Throughput Screening for Drug Discovery
    Genomic Technologies
    Drug Discovery
    Clinical Medicine
    New Antibiotics
    High Throughput Screening
    High Throughput Screening in Drug Discovery
    Proteomic Technologies
    A Proteomics Approach to Biomarker Discovery and Drug Development
    Other Technologies
    Epigenetics
    Epigenetics and Cancer Treatment
    Metabolomics
    Target Identification
    Target Validation
    Lead Optimization
    Mode of Action
    Preclinical Studies
    Clinical Studies
    Post-Approval Studies
    Diagnostics
    Combinatorial Chemistry
    Chemical Encoding
    Positional Encoding
    Electronic Encoding
    Synthetic Biology
    Systems Biology
    Computer Modelling
    Nanotechnology
    Artificial Intelligence (AI) in Drug Discovery
2. KEY MARKET TRENDS
3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE
4. KEY GLOBAL PLAYERS
  Agenus, Inc.
  Agilent Technologies Inc.
  Bio-rad Laboratories Inc.
  Bristol-Myers Squibb Company
  Bruker Corporation
  Charles River Laboratories
  Danaher Corp.
  Illumina Inc.
  Promega Corp.
  QIAGEN N.V.
  Revvity, Inc.
  Thermo Fisher Scientific Inc.
5. KEY BUSINESS TRENDS
6. GLOBAL MARKET OVERVIEW
  Global Market Overview by Technology
    Drug Discovery Technology Overview by Global Region
    Bioanalytical Assays
    Bioinformatics
    Cell Based Assays
    Genomic Technologies
    High Throughput Screening
    Proteomic Technologies
    Other Drug Discovery Technologies

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW
7. THE UNITED STATES
  United States Market Overview by Technology
  Major Market Players
8. EUROPE
  European Market Overview by Technology
  Major Market Players
9. ASIA-PACIFIC
  Asia-Pacific Market Overview by Technology
  Major Market Players
10. REST OF WORLD
  Rest of World Market Overview by Technology
  Major Market Players

PART C: GUIDE TO THE INDUSTRY

  NORTH AMERICA
  Canada
  United States
  EUROPE
  Belgium
  Denmark
  France
  Germany
  Iceland
  Ireland
  Italy
  Russia
  Sweden
  Switzerland
  The Netherlands
  The United Kingdom
  ASIA-PACIFIC
  Australia
  China
  India
  Japan
  Singapore
  Taiwan
  REST OF WORLD
  Israel

PART D: ANNEXURE

  RESEARCH METHODOLOGY
  FEEDBACK